Lorisk 11.25mg Injection

Lorisk 11.25mg Injection contains the active ingredient leuprolide acetate, a gonadotropin releasing hormone (GnRH) agonist. It is indicated for the treatment of prostate cancer in men, hormone-responsive breast cancer, endometriosis (tissue normally lining the uterus that grows outside it), and uterine fibroids (benign growths of the uterus) in women. The injection is also used to treat premature puberty, characterised by early physical development in children due to hormonal imbalances.

Do not receive this injection if you are allergic to leuprolide acetate, goserelin, triptorelin, or any other ingredient in this medicine. Before receiving treatment, inform your doctor if you have liver or kidney impairment. Report any undiagnosed abnormal uterine bleeding to your physician. This medicine is contraindicated in pregnancy or if you are planning to become pregnant.

During treatment, existing symptoms may temporarily worsen due to increased sex steroid levels in the body. Contact your doctor if this occurs. In children being treated, report any progressive brain tumour to your physician.

Before starting treatment, notify your doctor of any underlying medical conditions including diabetes, seizures, heart problems with chest pain, irregular heartbeats, depression, or increased risk of osteoporosis. This medicine is not recommended for patients with abnormal vaginal bleeding.

Women of childbearing age should use non-hormonal contraceptive methods during treatment with Lorisk 11.25mg Injection. Men with urinary obstruction or those who have undergone testicle removal should inform their doctor. Inform your physician if you experience spinal cord compression, urinary disorders, or haematuria (blood in the urine).

The Lorisk 11.25mg Injection is used in the treatment of the following: Prostate cancer Hormone-responsive breast cancer in perimenopausal (around menopause) women Endometriosis (a painful illness in which the tissue that normally lines the inside of the uterus grows outside of your uterus) Central precocious puberty (a child’s body begins to change into an adult too soon caused by a release of certain hormones)

Lorisk 11.25mg Injection decreases testosterone or estrogen production, depending on the treated condition. This helps to slow the growth of cancer cells, reduce the size of uterine fibroids, and alleviate the symptoms of endometriosis and early onset of puberty.

Lorisk 11.25mg Injection is usually administered in the arm, thigh or abdomen. If this injection is recommended for you, it will be given by a healthcare professional. Do not self-administer. Your physician will choose the dosage and administration frequency based on the medical condition because it differs for each person.

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious side effects of Lorisk 11.25mg Injection are: Severe rash, itching Shortness or difficulty in breath Cough with blood Pulmonary embolism Severe headache Common side effects of Lorisk 11.25mg Injection are: Altered blood sugar and cholesterol levels Injection site reactions Loss of appetite Abnormal liver function Swelling in the ankle or hand Difficulty sleeping, headache Mood swings, depression Weight changes Nausea, vomiting Vaginal dryness, bleeding Loss of interest in sexual intercourse Hot flushes Bone pain, muscle weakness Breast tenderness

During the treatment of breast cancer with Lorisk 11.25mg Injection, it is recommended to undergo regular checkups every three months in combination with an aromatase inhibitor. Do not receive this injection if you experience any abnormal vaginal bleeding. Consult your doctor immediately if you or your child is suffering from a headache even after treating it with painkillers, vision problems, buzzing, or ringing in the ear. If you have diabetes, ask your doctor to monitor your glucose and blood sugar levels regularly. Before starting, inform your doctor if you are still mensurating.